Frontotemporal dementia with amyotrophic lateral sclerosis: A clinical comparison of patients with and without repeat expansions in C9orf72

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 3, 2013, Pages 172-176

  Snowden, Julie S ^a,b   Harris, Jennifer ^a,b   Richardson, Anna ^a,b   Rollinson, Sara ^b   Thompson, Jennifer C ^a,b   Neary, David ^a,b   Mann, David M A ^b   Pickering Brown, Stuart ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; C9orf72; Clinical characteristics; Frontotemporal dementia; Psychosis

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; APATHY; ARTICLE; BEHAVIOR CHANGE; BULBAR PARALYSIS; COGNITION; DEMOGRAPHY; EMPATHY; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT SELECTION; PRIORITY JOURNAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DNA REPEAT EXPANSION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; PROTEINS;

EID: 84875719602     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.765485     Document Type: Article

References (19)

1. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanu-cleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011; 72: 245-56.
2. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72: 257-68.
3. Majounie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012: 11: 323-30.
4. Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurol. 2012; 11: 232-40.
5. Chio A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGCC hexanucleotide repeat expansion of C9orf72. Brain. 2012: 135: 784-93.
6. Millecamps S, Boillee S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, et al. Phenotype difference between ALS patients with expanded repeats in C9orf72 and patients with mutations in other ALS-related genes. J Med Genet. 2012; 49: 258-63.
7. Simon-Sanchez J, Dopper EGP, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, et al. The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain. 2012; 135: 723-35.
8. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AMT, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain. 2012; 135: 693-708.
9. Dobson-Stone C, Hallupp M, Bartley L, Shepherd CE, Halliday GM, Schofield PR, et al. C9orf72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology. 2012; 79: 995-1001.
10. Snowden JS, Thompson JC, Stopford CL, Richardson AMT, Gerhard A, Neary D, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathologi-cal relationships. Brain. 2011; 134: 2478-92.
11. Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005; 65: 1817-9.
12. Mackenzie IRA, Neumann M, Bigio E, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009; 117: 15-8.
13. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. An update. Acta Neuropathol. 2010; 119: 1-4.
14. Mackenzie IRA, Neumann M, Baborie A, Sampathu, DM, Du Plessis D, Jaros E, et al. A har monized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011; 122: 111-3.
15. McCombe PA, Henderson RD. Effects of gender in amyo-trophic lateral sclerosis. Gend Med. 2010; 7: 557-70.
16. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Konig I, Pijnenburg Y, et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates. Brain. 2003; 126: 2016-22.
17. Raaphorst J, Beeldman E, de Visser M, de Haan RJ, Schmand B. A systematic review of the behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012; 13: 493-501.
18. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges Jr. Neurobehavioural features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2011; 67: 826-30.
19. Katz JS, Katzberg HD, Woolley SC, Marklund SL, Andersen PM. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotroph Lateral Scler. 2012; 13: 567-9.